- 21 Dec 2020 10:01 AM
- Hungary Matters
The licence was issued in an expedited procedure.
The drug, which Egis started developing in April, could be used to treat coronavirus patients from mid-January.
Favipiravir is the second drug, after remdesivir, that has been licenced by the OGYÉI to treat Covid-19 patients.
Photo - for illustration purposes only: MTI